ARTICLE SUMMARY:
In introducing Triton, an iPad-based solution for quantifying blood loss in the OR, Gauss Surgical not only supplies hospitals with more accurate metrics than the ones they’re currently working with, but also provides insights that allow physicians to make decisions that impact patient outcomes and drive blood management operations and health economics for the hospital.
In a lot of respects , Gauss Surgical Inc. seems like a typical medtech start-up. Developers of a system for intraoperatively monitoring and quantifying blood loss during surgery, replacing today’s inaccurate methods for doing so, Gauss’ Triton system gained 510(k) clearance under the de novo pathway in 2014 and is sold to hospitals by experienced medical device reps.
